Is one dose ever enough? The PROSPECTOR 🪓 Trial will answer - A international double blind placebo controlled trial of 1 dose vs 5 day for #penicillinallergy. This week we recruited our 100th patient! 🎉 @thedohertyinst.bsky.social

The largest adult #penicillinallergy study ever undertaken - The iNAAN study @thedohertyinst.bsky.social @unimelb.bsky.social - 52 hospitals, 8 countries and over 5000 patients….Real world proof of the safety and effectiveness of inpatient DOC! Stay tuned #AMS folks 👀Results soon!

🆕🔥State-of-the-Art Review with 🌟s @trubianojason.bsky.social : Antibiotic Allergy—A Multidisciplinary Approach to Delabeling #idsky url: academic.oup.com/cid/article/...

The SULF-FAST tool, used to assess sulfonamide allergy risk, successfully identified patients with low risk for safe oral challenges, resulting in a 95% rate of negative reactions. https://ja.ma/45ZxzLq

Penicillin allergy delabelling is an effective form of antimicrobial stewardship. And can be pharmacist-led. 👏 @elisemitri.bsky.social @trubianojason.bsky.social #IDSky #AMR #ClinMicro @cmicomms.bsky.social